Besides, additional studies are required to assess the efficacy of NET-, NLRP3-, and pyroptosis-targeted strategies for the treatment of ED in DM patients, which is essential for the translation of these findings into clinically therapeutic approaches. The gene discussed is NLRP3; the disease is diabetes mellitus.